What investigation to do when a peripheral smear shows microcytic hypochromic anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Approach for Microcytic Hypochromic Anemia

When peripheral smear shows microcytic hypochromic anemia, a systematic diagnostic workup should begin with iron studies including serum ferritin, transferrin saturation (TSAT), and complete blood count parameters to differentiate between the most common causes. 1

Initial Laboratory Evaluation

  • Complete Blood Count (CBC) - Evaluate MCV, RDW, and RBC count
  • Iron Studies:
    • Serum ferritin
    • Serum iron
    • Total iron binding capacity (TIBC)
    • Transferrin saturation (TSAT)
  • Free erythrocyte protoporphyrin - Helps distinguish between different causes 2

Differential Diagnosis Parameters

Parameter Iron Deficiency Thalassemia Trait Anemia of Chronic Disease
MCV Low Very low (<70 fl) Low/Normal
RDW High (>14%) Normal (≤14%) Normal/Slightly elevated
Ferritin Low (<30 μg/L) Normal Normal/High
TSAT Low Normal Low
RBC count Normal/Low Normal/High Normal/Low

Diagnostic Algorithm

  1. First-line test: Serum ferritin

    • If low (<30 μg/L): Consistent with iron deficiency anemia
    • If normal or elevated: Proceed to next tests 2
  2. Second-line tests (if ferritin normal or elevated):

    • Serum iron level and TIBC
    • Free erythrocyte protoporphyrin
    • Hemoglobin electrophoresis (to rule out hemoglobinopathies)
  3. Interpretation of second-line tests:

    • Low serum iron + elevated protoporphyrin + normal/high ferritin: Anemia of chronic disease
    • Normal/high serum iron + normal protoporphyrin: Consider thalassemia or hemoglobinopathies
    • Low serum iron + elevated protoporphyrin + elevated lead levels: Consider lead toxicity 2
  4. Additional tests based on suspected diagnosis:

    • For suspected genetic disorders of iron metabolism or heme synthesis:
      • ALAS2 gene testing (for X-linked sideroblastic anemia)
      • GLRX5 testing (for sideroblastic anemia with iron loading)
      • Bone marrow examination for ring sideroblasts 3

Special Considerations

  • Inflammatory conditions: In patients with chronic inflammation, ferritin may be falsely normal or elevated despite iron deficiency. Consider measuring soluble transferrin receptor (sTfR) or sTfR/ferritin ratio in these cases 4

  • Sideroblastic anemia: If iron parameters suggest iron loading with microcytic anemia, consider bone marrow examination to look for ring sideroblasts 3

  • Rare genetic disorders: In cases where common causes are excluded, consider:

    • Iron-refractory iron deficiency anemia (IRIDA)
    • Defects in mitochondrial iron utilization
    • Defects in iron recycling 5

Common Pitfalls to Avoid

  • Accepting a positive dietary history as the sole cause of iron deficiency anemia without further investigation

  • Misinterpreting ferritin levels in the presence of inflammation

  • Inadequate duration of iron therapy before reassessment

  • Deferring iron replacement while awaiting investigations 1

  • Failure to consider genetic causes of microcytic anemia when standard treatments fail 6

Remember that the definitive test for iron deficiency remains the absence of iron stores in bone marrow examination, but this is usually reserved for cases where non-invasive testing is inconclusive 7.

References

Guideline

Anemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

How I manage patients with atypical microcytic anaemia.

British journal of haematology, 2013

Research

How I Diagnose Non-thalassemic Microcytic Anemias.

Seminars in hematology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.